http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-6700851-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dbe6a152ab369ec0c2c593941a1ee036
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C55-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D489-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
filingDate 2013-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9579426eccaba543c8f42882e8290cba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d009dddd14f951c53a7a81704035d9de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0db70f825d6f74b919547b978a13bbbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bcbc18a1e59aa4387dd2c77a4ea5da1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0be44fc685a679820e48f69f43422cd2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2ce3ebeafca87c84f03b7b00cdb2069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcc89ca117358dbb78a172bf5cc70229
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bd2f753d4f808604e006136537c7f21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c267caee47ca922a2a2b463491d04370
publicationDate 2013-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CO-6700851-A2
titleOfInvention Conjugate of crystalline naloxol-peg
abstract Naloxol-polyethylene glycol conjugates of the formula are provided: in salt forms of oxalate or phosphate type, including crystalline forms. Methods for preparing the salt forms and pharmaceutical compositions comprising the salt forms are also provided.
priorityDate 2010-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411471813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71081

Total number of triples: 31.